📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
0
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration
15%
• Score climbed 8 points (worsening)
💹 Market Data
Market Cap$1.24M
Shares Outstanding2.48B
Float2.17B
CashN/A
Debt$150.0K
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest72.2K
Days to Cover1.0
% of FloatN/A
FINRA data as of Dec 31, 2025
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2024
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for AHRO
📊 AHRO FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 AHRO Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.